Encision

ECIA · OTC

$0.0115+$0.1382 (−109.08%)TodayMarket closed ·
No price history for this range.

About ECIA

Encision, Inc. is a medical device company, which engages in the designing, developing, and manufacturing of patented surgical instruments in the United States. The company is headquartered in Boulder, Colorado and currently employs 22 full-time employees. The company designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees
22
Headquarters
Boulder, Colorado
Listed
Jun 25, 1996
Sector
Health Care
Industry
Health Care Equipment & Supplies

ECIA key statistics

Market cap
194.12K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
15.88K
Volume
3
Open price
$0.0412
High today
$0.0412
Low today
$0.0115
52 Week high
$0.3895
52 Week low
$0.0002

Encision (ECIA) at a glance

As of Oct 5, 2026, Encision (ECIA) shares are priced at $0.0115, giving the company a market cap of 194.12K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.0115 and $0.0412. The current price is 0.0% above the day's low and 72.1% below its high.

Volume so far is 3 shares, below the average of 15.88K shares a day.

Over the past year Encision has ranged from $0.0002 to $0.3895, and now sits 3% of the way up that range.

Encision met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q3 FY25 it reported $0.00 per share against an estimate of $0.00.

ECIA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 87.3% on average.

  1. Q2 FY97: reported -$0.07 per share against an estimate of -$0.0816
  2. Q4 FY97: reported -$0.33 per share against an estimate of -$0.0816
  3. Q2 FY98: reported -$0.17 per share against an estimate of -$0.1428
  4. Q3 FY98: reported -$0.15 per share against an estimate of -$0.1122
  5. Q4 FY98: reported $0.08 per share against an estimate of -$0.1326
  6. Q1 FY99: reported -$0.11 per share against an estimate of -$0.0918
  7. Q2 FY24: reported $0.00 per share against an estimate of $0.00
  8. Q3 FY25: reported $0.00 per share against an estimate of $0.00

ECIA news

  • Press releaseACCESSWIRE

    Encision Reports Second Quarter Fiscal Year 2025 Results

Similar companies

Companies in the same industry as Encision

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.